Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Market capitalization of selected larger gene and cell therapy companies in the U.S. as of 2017 (in billion U.S. dollars)*
Market cap of larger gene and cell therapy companies in U.S. as of 2017
This statistic shows the market capitalization of select larger gene and cell therapy companies which were listed in the U.S., as of 2017. The market capitalization of Bluebird Bio, an oncology gene therapy company, was 3.7 billion U.S. dollars.
Market capitalization of selected larger gene and cell therapy companies in the U.S. as of 2017 (in billion U.S. dollars)*
Market cap in billion U.S. dollars
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2017

Region

United States

Survey time period

as of 2017

Supplementary notes

* Listed on NASDAQ Biotech.

Market cap of larger gene and cell therapy companies in U.S. as of 2017
This statistic shows the market capitalization of select larger gene and cell therapy companies which were listed in the U.S., as of 2017. The market capitalization of Bluebird Bio, an oncology gene therapy company, was 3.7 billion U.S. dollars.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Cell and gene therapy"
  • Market overview
  • R&D/trials
  • Stem cells
  • Cord blood
  • CAR/CAR-T
  • Miscellaneous
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.